JPMorgan Chase & Co’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-247,830
| Closed | -$5.18M | – | 4689 |
|
|
2016
Q3 | $5.18M | Sell |
247,830
-71,270
| -22% | -$1.49M | ﹤0.01% | 1979 |
|
|
2016
Q2 | $3.44M | Buy |
319,100
+130,300
| +69% | +$1.41M | ﹤0.01% | 2210 |
|
|
2016
Q1 | $1.25M | Sell |
188,800
-14,829
| -7% | -$98.3K | ﹤0.01% | 2584 |
|
|
2015
Q4 | $3.69M | Sell |
203,629
-195,164
| -49% | -$3.53M | ﹤0.01% | 2097 |
|
|
2015
Q3 | $4.39M | Buy |
398,793
+158,393
| +66% | +$1.74M | ﹤0.01% | 2015 |
|
|
2015
Q2 | $3.46M | Sell |
240,400
-20,760
| -8% | -$299K | ﹤0.01% | 2269 |
|
|
2015
Q1 | $3.06M | Buy |
261,160
+160,560
| +160% | +$1.88M | ﹤0.01% | 2346 |
|
|
2014
Q4 | $1.67M | Sell |
100,600
-24,400
| -20% | -$406K | ﹤0.01% | 2565 |
|
|
2014
Q3 | $953K | Buy |
+125,000
| New | +$953K | ﹤0.01% | 2775 |
|